HARP
Harpoon Therapeutics, Inc. Common Stock
HARP
HARP
Delisted
HARP was delisted on the 8th of March, 2024.
77 hedge funds and large institutions have $330M invested in Harpoon Therapeutics, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 23 increasing their positions, 20 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
14% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 14
75% less call options, than puts
Call options by funds: $674K | Put options by funds: $2.72M
Holders
77
Holding in Top 10
3
Calls
$674K
Puts
$2.72M
Top Buyers
| 1 | +$3.82M | |
| 2 | +$3.01M | |
| 3 | +$2.31M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$1.35M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.24M |
Top Sellers
| 1 | -$6.92M | |
| 2 | -$6.42M | |
| 3 | -$1.87M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$889K |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$722K |